The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumours

---

YILMAZ B., Erdem D., Teker F., Gören İ., YILDIRIM B., Kut E., ...Daha Fazla

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, cilt.44, sa.3, ss.627-638, 2016 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 44 Sayı: 3
• Basım Tarihi: 2016
• Doi Numarası: 10.1177/0300060516638992
• Dergi Adı: JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.627-638
• Anahtar Kelimeler: Hepatitis B virus reactivation, hepatitis B surface antibody, chemotherapy, solid tumour, haematological malignancy, VIRUS HBV REACTIVATION, BREAST-CANCER PATIENTS, RECEIVING CYTOTOXIC CHEMOTHERAPY, LYMPHOMA PATIENTS, RISK-FACTORS, POSITIVE PATIENTS, CELL LYMPHOMA, LAMIVUDINE, INFECTION, METAANALYSIS
• Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Objective To investigate the effect of immunosuppressive anticancer therapy on titre levels of anti-hepatitis B surface antibodies (anti-HBs) in hepatitis B surface antigen (HBsAg) negative and anti-HBs positive patients with haematological malignancies or solid tumours.